Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity
about
Top-down proteomics in health and disease: challenges and opportunitiesMass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesElevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MSThe emergence of top-down proteomics in clinical researchRapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumCys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Top-down proteomics of a drop of blood for diabetes monitoring.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.Maillard Proteomics: Opening New Pages.
P2860
Q27002139-6CFD4193-ECDF-421C-BBC2-39FA0C56FAB8Q33643266-BE5DC23F-0362-4FC1-A36B-7E95BA4EFA30Q33850682-AAB6E356-65A9-4939-8188-CB97562D0B9BQ36977460-25E2BDE7-D375-4BF1-BF14-DE80636CA60AQ36998685-9CF5CB7B-F48C-4E59-8D3A-81A29CD61E64Q37187946-D444E559-7BF1-4FBA-9AF6-8E8CF6EFD368Q37453196-A02556D5-25DE-43A5-9382-C271F22AC822Q37566426-1492070F-AF07-4E30-BD50-A2897BA55214Q37714134-0BB0C502-3DAB-4B2E-B9DB-C377F7A3E533Q38151611-3DEAA2D2-2A12-41A9-BB01-30105BB7EE16Q38552059-A41708ED-EF1E-48A1-B4FF-BD8838DB572EQ39079275-56FED30B-D245-4D5D-AFAB-B5230E1005F7Q46825370-49CF5EE4-4356-48D3-A367-BDE0FD513AC2Q47303198-76381D47-38EF-4AB4-AD78-D611B08EB782
P2860
Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Building multidimensional biom ...... of protein microheterogeneity
@ast
Building multidimensional biom ...... of protein microheterogeneity
@en
type
label
Building multidimensional biom ...... of protein microheterogeneity
@ast
Building multidimensional biom ...... of protein microheterogeneity
@en
prefLabel
Building multidimensional biom ...... of protein microheterogeneity
@ast
Building multidimensional biom ...... of protein microheterogeneity
@en
P2093
P2860
P1433
P1476
Building multidimensional biom ...... of protein microheterogeneity
@en
P2093
Chad R Borges
Douglas S Rehder
Jason W Jarvis
Matthew R Schaab
Paul E Oran
Randall W Nelson
Stephen P Rogers
Thomas Taylor
P2860
P304
P356
10.1373/CLINCHEM.2010.156976
P407
P577
2011-03-14T00:00:00Z